This adds up to $16680 per year without insurance, coupons, or financial assistance
If youre an employer feeling the impact of GLP-1 challenges, contact us to talk about what a weight management program could look like for your organization
Retatrutide (LY-3437943) is a synthetic triple-receptor agonist peptide that Durham Peptides supplies as research-grade 10 mg lyophilized vials, stocked and shipped domestically for researchers across Canada
Symptoms are typically mild and go away within 13 days
The medication could degrade, leading to potential adverse reactions
Routine iron monitoring is not mandated for all patients taking Wegovy, but individualised assessment based on risk factors and symptoms may be appropriate, particularly for those at higher risk of deficiency